Yao He

856 total citations
22 papers, 648 citations indexed

About

Yao He is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yao He has authored 22 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Yao He's work include Cancer-related molecular mechanisms research (7 papers), Urinary Bladder and Prostate Research (5 papers) and Renal and related cancers (4 papers). Yao He is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Urinary Bladder and Prostate Research (5 papers) and Renal and related cancers (4 papers). Yao He collaborates with scholars based in China, Germany and Zimbabwe. Yao He's co-authors include Zhi Chen, Xiang Chen, Bo Zhang, Yuhang Liu, Guoyu Dai, Weiping Xia, Peihua Liu, Yu Gan, Bo Zhang and Bingsheng Li and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Experimental Cell Research.

In The Last Decade

Yao He

22 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yao He China 14 328 245 223 85 61 22 648
Fangyou Lin China 11 177 0.5× 101 0.4× 161 0.7× 48 0.6× 36 0.6× 25 379
Guoyu Dai China 9 170 0.5× 128 0.5× 148 0.7× 50 0.6× 31 0.5× 16 367
You Luo China 16 98 0.3× 102 0.4× 86 0.4× 30 0.4× 47 0.8× 34 458
Qingzhi Long China 12 210 0.6× 107 0.4× 148 0.7× 11 0.1× 34 0.6× 28 502
Bohao Liu China 12 182 0.6× 113 0.5× 55 0.2× 76 0.9× 54 0.9× 25 492
Huzi Xu China 9 278 0.8× 135 0.6× 170 0.8× 90 1.1× 42 0.7× 16 473
Han Zhu China 12 316 1.0× 134 0.5× 170 0.8× 148 1.7× 63 1.0× 19 618
Naijun Miao China 18 434 1.3× 61 0.2× 87 0.4× 210 2.5× 177 2.9× 21 807
Zongyu Zheng United States 17 404 1.2× 77 0.3× 80 0.4× 222 2.6× 163 2.7× 27 830
Rohit Upadhyay India 18 447 1.4× 169 0.7× 93 0.4× 13 0.2× 55 0.9× 49 743

Countries citing papers authored by Yao He

Since Specialization
Citations

This map shows the geographic impact of Yao He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yao He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yao He more than expected).

Fields of papers citing papers by Yao He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yao He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yao He. The network helps show where Yao He may publish in the future.

Co-authorship network of co-authors of Yao He

This figure shows the co-authorship network connecting the top 25 collaborators of Yao He. A scholar is included among the top collaborators of Yao He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yao He. Yao He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gan, Yu, Kangning Wang, Xiang Chen, et al.. (2025). Senolytic procyanidin C1 alleviates renal fibrosis by promoting apoptosis of senescent renal tubular epithelial cells. The FASEB Journal. 39(2). e70362–e70362. 4 indexed citations
2.
Cai, Yi, Minfeng Chen, Jiaxian Chen, et al.. (2024). Androgen‐repressed lncRNA LINC01126 drives castration‐resistant prostate cancer by regulating the switch between O‐GlcNAcylation and phosphorylation of androgen receptor. Clinical and Translational Medicine. 14(1). e1531–e1531. 8 indexed citations
3.
Zhang, Bo, Xiang Chen, Ru Feng, et al.. (2021). Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis. Cell Death and Disease. 12(9). 843–843. 158 indexed citations
4.
Xia, Weiping, Yao He, Yu Gan, et al.. (2021). Long Non-coding RNA: An Emerging Contributor and Potential Therapeutic Target in Renal Fibrosis. Frontiers in Genetics. 12. 682904–682904. 20 indexed citations
5.
Xia, Weiping, Xiang Chen, Ru Feng, et al.. (2021). Knockdown of lncRNA XIST inhibited apoptosis and inflammation in renal fibrosis via microRNA-19b-mediated downregulation of SOX6. Molecular Immunology. 139. 87–96. 23 indexed citations
6.
Qiao, Jing, Yu Gan, Bo Zhang, et al.. (2021). Combination therapy with curcumin plus tamsulosin and finasteride in the treatment of men with benign prostatic hyperplasia: a single center, randomized control study. Translational Andrology and Urology. 10(8). 3432–3439. 9 indexed citations
7.
Li, Bingsheng, et al.. (2021). Leptin Receptor Overlapping Transcript (LEPROT) Is Associated with the Tumor Microenvironment and a Prognostic Predictor in Pan-Cancer. Frontiers in Genetics. 12. 749435–749435. 2 indexed citations
8.
Long, Zhi, Liang Deng, Chao Li, et al.. (2021). Loss of EHF facilitates the development of treatment-induced neuroendocrine prostate cancer. Cell Death and Disease. 12(1). 46–46. 15 indexed citations
9.
Zhang, Bo, Xiang Chen, Yu Gan, et al.. (2021). Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation. Annals of Translational Medicine. 9(15). 1246–1246. 7 indexed citations
10.
11.
Liu, Yuhang, Zhaohui Wang, Yu Gan, et al.. (2021). Curcumin attenuates prostatic hyperplasia caused by inflammation via up-regulation of bone morphogenetic protein and activin membrane-bound inhibitor. Pharmaceutical Biology. 59(1). 1024–1033. 7 indexed citations
12.
Zhang, Bo, Xiang Chen, Yu Gan, et al.. (2020). Periprostatic fat thickness measured on MRI correlates with lower urinary tract symptoms, erectile function, and benign prostatic hyperplasia progression. Asian Journal of Andrology. 23(1). 80–84. 4 indexed citations
13.
14.
Zhang, Bo, Peihua Liu, Yan Zhou, et al.. (2019). Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation. Life Sciences. 223. 29–37. 38 indexed citations
15.
Liu, Peihua, Zhi Chen, Yao He, et al.. (2019). PTEN improve renal fibrosis in vitro and in vivo through inhibiting FAK/AKT signaling pathway. Journal of Cellular Biochemistry. 120(10). 17887–17897. 33 indexed citations
16.
He, Cheng, Zhiyong Chen, Li Yang, et al.. (2019). miR-10b suppresses cell invasion and metastasis through targeting HOXA3 regulated by FAK/YAP signaling pathway in clear-cell renal cell carcinoma. BMC Nephrology. 20(1). 127–127. 19 indexed citations
17.
Zhang, Bo, Xiang Chen, Zhi Chen, et al.. (2019). Leptin promotes epithelial-mesenchymal transition in benign prostatic hyperplasia through downregulation of BAMBI. Experimental Cell Research. 387(1). 111754–111754. 14 indexed citations
18.
Wang, Zhaohui, Bo Zhang, Yao He, et al.. (2019). The long noncoding RNA myocardial infarction-associated transcript modulates the epithelial-mesenchymal transition in renal interstitial fibrosis. Life Sciences. 241. 117187–117187. 22 indexed citations
19.
Ou, Zhenyu, Yao He, Lin Qi, et al.. (2017). Infiltrating mast cells enhance benign prostatic hyperplasia through IL-6/STAT3/Cyclin D1 signals. Oncotarget. 8(35). 59156–59164. 22 indexed citations
20.
He, Yao, Zhenyu Ou, Xiang Chen, et al.. (2016). LPS/TLR4 Signaling Enhances TGF-β Response Through Downregulating BAMBI During Prostatic Hyperplasia. Scientific Reports. 6(1). 27051–27051. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fangyou Lin Breakdown of academic impact, for papers by Guoyu Dai Breakdown of academic impact, for papers by You Luo Breakdown of academic impact, for papers by Qingzhi Long Breakdown of academic impact, for papers by Bohao Liu Breakdown of academic impact, for papers by Huzi Xu Breakdown of academic impact, for papers by Han Zhu Breakdown of academic impact, for papers by Naijun Miao Breakdown of academic impact, for papers by Zongyu Zheng Breakdown of academic impact, for papers by Rohit Upadhyay
Rankless by CCL
2026